secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001193125-24-056966
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar Therapeutics raises $30M via pre-funded warrant to TCG Crossover Fund
----------------------------------------------------------------------------

- Issued pre-funded warrant to purchase 25M shares of common stock at $1.20 per share, total $30M.
- Exercise price of warrant is $0.0001 per share; purchaser cannot exceed 9.99% beneficial ownership without notice.
- Closing expected on or before March 6, 2024; exempt from registration under Section 4(a)(2) and Rule 506(b).
- Company to file resale registration statement for warrant shares within 90 days after closing.
- Use of proceeds not specified; proceeds before expenses are $30M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000119312524056966/0001193125-24-056966-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000119312524056966/d762406d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-056966

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer